There’s still hope GLP-1 drugs could slow the second-biggest type of dementia
Can GLP-1s treat vascular dementia? One study failed, but some researchers are holding out hope.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
